Johnson & Johnson have just announced that they are planning to urge doctors to return their power morcellators that may be linked to the spreading of cancer in women who are treated for fibroids (uterine growths). The news comes as a shock, as the device has been used with success for years. The controversial surgical device has been targeted in the past with various accusations, but today … [Read more...]
J&J suspends worldwide sale of fibroid surgery device following FDA advisory
Drug maker Johnson & Johnson has called off the worldwide sale of its fibroid surgery device as threat looms larger over its potential to spread undetected cancer beyond the uterus. The development comes following a Food and Drug Administration (FDA) advisory on April 17 that asked the doctors from using laparoscopic power morcellators to remove fibroids amid risk of worsening an … [Read more...]
FDA’s no to wider use of Johnson & Johnson’s Xarelto drug
In a major setback to drug maker Johnson & Johnson, the US Food and Drug Administration has rejected its drug application for a third time. The firm has sought permission from the agency to expand use of the blood thinner Xarelto to reduce dangerous blood clots and related problems in patients with coronary artery disease. But much to the disappointment for the company, the FDA rejected its … [Read more...]
Johnson & Johnson takes giant step, announces sharing of clinical trial data with Yale
Taking a major step in the field of medical researches, leading drug maker Johnson & Johnson has announce sharing of clinical trial data sharing with the Yale School of Medicine. Till now, drug companies observed secrecy as far as their medicine studies were concerned. The raw information related to drugs, devices, and other products was only viewed by the U.S. Food and Drug Administration. … [Read more...]
